Cxcr3 and its ligands are associated with a T cell inflamed signature in many cancers [12] and plasma levels of Cxcl9 and Cxcl10 are associated with prolonged survival in PDA patients treated with chemotherapy [15]. This evidence concerns the gene CXCR3 and Patent ductus arteriosus.